Document is current
Any future updates will be listed below
-
Authors
Ciudin, Andreea https://orcid.org/0000-0001-5622-0203
Sapin, Helene https://orcid.org/0000-0003-2602-8450
Fan, Ludi https://orcid.org/0000-0001-9298-8025
Dimitriadis, Georgios K. https://orcid.org/0000-0002-6662-804X
Zimner-Rapuch, Sarah https://orcid.org/0009-0008-6687-1921
Curteis, Tristan
Clark, Laura J. https://orcid.org/0000-0003-4378-2420
Rubinstein, Manon
Johansson, Erin https://orcid.org/0009-0006-3178-1622
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 23 October 2025
Accepted: 3 February 2026
First Online: 12 March 2026
Declarations
:
: Andreea Ciudin: Honoraria from AstraZeneca, Boehringer Ingelheim, Lilly, Novo Nordisk; Member of the DMC of Boehringer Ingelheim clinical trials-SYNCRONIZE program; Helene Sapin, Ludi Fan, Georgios K. Dimitriadis, Sarah Zimner-Rapuch, Erin Johansson: Employees and shareholders of Eli Lilly and Company; Tristan Curteis, Laura J. Clark, Manon Rubinstein: Employees of Costello Medical, which received payment from Eli Lilly and Company for analytical services for this study.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
